Capecitabine | CAS 154361-50-9 - Request Quote
Capecitabine
| SZ CAT No: | SZ-C003001 |
| CAS No | 154361-50-9 |
| Mol.F. | C15H22FN3O6 |
| Mol.Wt. | 359.4 |
| Inv. Status | In Stock |
| Rel. CAS No | 1370587-15-7 (HCl salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Capecitabine is chemically Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate (as per EP) ; Pentyl 1-(5-deoxy-β-d-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate (as per USP). Capecitabine is supplied with detailed characterization data compliant with regulatory guideline. Capecitabine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Capecitabine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 154361-50-9
Purchase 154361-50-9
Order 154361-50-9
Enquire 154361-50-9
price of 154361-50-9
154361-50-9 Supplier
154361-50-9 Manufacturer
154361-50-9 Exporter
buy high quality Capecitabine
Purchase Capecitabine
Capecitabine suppliers
Capecitabine manufacturers
Capecitabine price
Order Capecitabine
Enquire Capecitabine
Capecitabine cost
Capecitabine Supplier
Capecitabine Distributor
Capecitabine for Method Validation
Capecitabine Reference Standard
Capecitabine for ANDA Filing
Capecitabine for Forced Degradation Studies
Capecitabine Identification Standards
Capecitabine for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.